Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:MYMD NASDAQ:TCBP NASDAQ:TFFP OTCMKTS:WCUI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMYMDMyMD Pharmaceuticals$0.09-13.1%$0.15$1.75▼$63.90$224K2.15134,123 shs16.98 million shsTCBPTC Biopharm$0.68-55.8%$0.68$0.50▼$160.00$279K0.01173,739 shs5.33 million shsTFFPTFF Pharmaceuticals$0.07$0.06$0.06▼$3.23$289K0.981.02 million shsN/AWCUIWellness Center Usa$0.00$0.00$0.00▼$0.00$14K4.8950 shs65,499 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMYMDMyMD Pharmaceuticals+2.64%-13.70%-25.34%-40.50%-94.29%TCBPTC Biopharm0.00%0.00%0.00%0.00%-99.52%TFFPTFF Pharmaceuticals0.00%0.00%0.00%0.00%-96.64%WCUIWellness Center Usa0.00%0.00%-81.82%0.00%-87.50%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMYMDMyMD PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ATCBPTC Biopharm1.4835 of 5 stars3.50.00.00.00.60.80.6TFFPTFF PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AWCUIWellness Center UsaN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMYMDMyMD Pharmaceuticals 0.00N/AN/AN/ATCBPTC Biopharm 3.00Buy$48.006,948.46% UpsideTFFPTFF Pharmaceuticals 0.00N/AN/AN/AWCUIWellness Center Usa 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMYMDMyMD PharmaceuticalsN/AN/AN/AN/A$7.21 per shareN/ATCBPTC Biopharm$4.76M0.06N/AN/A$519.58 per share0.00TFFPTFF Pharmaceuticals$730K0.40N/AN/A$4.04 per share0.02WCUIWellness Center Usa$660K0.02N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMYMDMyMD Pharmaceuticals-$4MN/A0.00∞N/AN/A-179.05%-108.14%N/ATCBPTC Biopharm-$7.35MN/A0.00∞N/AN/AN/AN/AN/ATFFPTFF Pharmaceuticals-$21.24M-$6.44N/A∞N/AN/AN/AN/AN/AWCUIWellness Center Usa-$750KN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMYMDMyMD PharmaceuticalsN/AN/AN/AN/AN/ATCBPTC BiopharmN/AN/AN/AN/AN/ATFFPTFF PharmaceuticalsN/AN/AN/AN/AN/AWCUIWellness Center UsaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMYMDMyMD PharmaceuticalsN/A0.620.62TCBPTC Biopharm0.671.12N/ATFFPTFF PharmaceuticalsN/AN/AN/AWCUIWellness Center UsaN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMYMDMyMD Pharmaceuticals9.64%TCBPTC Biopharm16.25%TFFPTFF Pharmaceuticals15.25%WCUIWellness Center Usa0.01%Insider OwnershipCompanyInsider OwnershipMYMDMyMD Pharmaceuticals2.12%TCBPTC Biopharm15.44%TFFPTFF Pharmaceuticals4.50%WCUIWellness Center Usa15.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMYMDMyMD Pharmaceuticals62.37 million2.32 millionOptionableTCBPTC Biopharm80410,00028,000Not OptionableTFFPTFF Pharmaceuticals194.44 million4.24 millionOptionableWCUIWellness Center Usa8143.19 million120.71 millionNot OptionableWCUI, TFFP, MYMD, and TCBP HeadlinesRecent News About These CompaniesHealing begins where taboos end at SIU Pelvic Wellness CenterJuly 16 at 5:34 PM | nprillinois.orgNRagin Wellness Center offering trauma therapy to young people in SumterJuly 16 at 5:34 PM | abccolumbia.comA5 walkouts of mentally ill patients prompt policy reform at Guam Behavioral Health and Wellness CenterJuly 13, 2025 | guampdn.comGForty Fort Parks and Recreation Committee donates to Cancer Wellness Center of NEPAJuly 13, 2025 | timesleader.comTLamar Mental Wellness Center in Augusta aids mental health needsJuly 11, 2025 | msn.comFlagler Schools cut ribbon on new Wellness CenterJuly 9, 2025 | observerlocalnews.comOWest Monroe Honors Local Businesses with “Yard of the Month” Award for Outstanding Beautification to The Wellness CenterJuly 5, 2025 | msn.comAvas Wellness Center and Spa to Anchor a Growing Wellness-Driven Ecosystem in AlibaugJuly 2, 2025 | devdiscourse.comDErie Cancer Wellness Center Free Outdoor Summer Wellness Series July 10July 1, 2025 | erienewsnow.comE‘Shocked’: North Portland Wellness Center scorched by 3-alarm fireJune 10, 2025 | msn.comWildcat Wellness Center set to close in July for summer breakJune 4, 2025 | msn.comSenior wellness expo draws increased attendance at YMCA Wellness CenterMay 21, 2025 | msn.comLumiClinics Behavioral Wellness Center Revolutionizes Mental Health Care with Integrated ApproachMay 17, 2025 | news.marketersmedia.comNCancer Wellness Center of NEPA holds Annual WalkMay 12, 2025 | timesleader.comTCancer Wellness Center gears up for major walk fundraiserMay 7, 2025 | msn.comWellness Center attendance upApril 16, 2025 | sdsucollegian.comSMCCTC Plans New Health and Wellness CenterApril 11, 2025 | businessjournaldaily.comBRegional Wellness Center project planning on pause amid funding uncertaintyApril 11, 2025 | duboiscountyfreepress.comDVictorville’s Wellness Center receives major funding from San Bernardino CountyApril 11, 2025 | msn.comUSD To Host Wellness Center Natatorium Grand Opening And Ribbon CuttingApril 11, 2025 | plaintalk.netPNew MarketBeat Followers Over TimeMedia Sentiment Over TimeWCUI, TFFP, MYMD, and TCBP Company DescriptionsMyMD Pharmaceuticals NASDAQ:MYMD$0.09 -0.01 (-13.12%) As of 07/17/2025MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic analog of cannabidiol for treating epilepsy, pain, and anxiety/depression. The company was founded in 2014 and is headquartered in Baltimore, Maryland.TC Biopharm NASDAQ:TCBPTC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.TFF Pharmaceuticals NASDAQ:TFFPTFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment and prophylaxis of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It also develops other dry powder products, such as Augmenta human derived monoclonal antibodies for the treatment of COVID-19 disease; and other vaccines. It has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs. TFF Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Fort Worth, Texas.Wellness Center Usa OTCMKTS:WCUI$0.0001 0.00 (0.00%) As of 07/17/2025 01:00 PM EasternWellness Center USA, Inc. engages in the healthcare and medical business in the United States and internationally. The company operates through Medical Devices; and Authentication and Encryption Products and Services segments. It is primarily involved in the marketing and distribution of online sports and nutrition supplements. The company also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices that include Psoria-Light, which is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, it offers intelligent microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence service comprising proprietary, unprecedented, and actionable technology, which include a suite of analytical tools, such as artificial intelligence and social psychology for industries, companies, and agencies. The company was incorporated in 2010 and is based in Tucson, Arizona. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
